Charles Retina Institute

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease1 trial
• Macular degeneration1 trial

Phase

• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Genentech, Inc.1 trial
• Gyroscope Therapeutics Limited1 trial

Running trials

• Active, not recruiting

  A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema

  NCT05224102· Phase 4· Genentech, Inc.· Source

Closed trials

• Terminated

  EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04437368· Phase 2· Gyroscope Therapeutics Limited· Source